Lusutrombopag

CHEMBL2107831 Phase 4 Approuvé Small molecule
Half-Life
Bioavailability
Protein Binding
Molecular Weight
591.5 g/mol
LogP
7.7
Phase
4

A small-molecule thrombopoietin receptor agonist used to treat low platelet counts in adults with chronic liver disease preparing for a scheduled procedure. It stimulates the bone marrow to produce more platelets.

Masse moléculaire

591,5000 g/mol

LogP

7,70

TPSA

126,00 Ų

Règle des 5 de Lipinski

Non conforme

Aires thérapeutiques

Mécanisme d'action

Binds to and activates its target receptor, mimicking the action of the endogenous ligand to produce a specific physiological response.

Pharmacokinetics (PK)

Pharmacodynamics (PD)

Mécanisme

Binds to and activates its target receptor, mimicking the action of the endogenous ligand to produce a specific physiological response.

Structure 2D

SVG PNG

Cite this structure


                        

Embed this structure


                        

SMILES

CCCCCCO[C@@H](C)c1cccc(-c2csc(NC(=O)c3cc(Cl)c(/C=C(\C)C(=O)O)c(Cl)c3)n2)c1OC

InChI

InChI=1S/C29H32Cl2N2O5S/c1-5-6-7-8-12-38-18(3)20-10-9-11-21(26(20)37-4)25-16-39-29(32-25)33-27(34)19-14-23(30)22(24(31)15-19)13-17(2)28(35)36/h9-11,13-16,18H,5-8,12H2,1-4H3,(H,35,36)(H,32,33,34)/b17-13+/t18-/m0/s1

Molecular Formula

C29H32Cl2N2O5S

HBD / HBA

2 / 7

Liaisons Rotatives

13

Atomes Lourds

39

No targets recorded

Target interaction data is not yet available for this drug.

No interactions recorded

Drug interaction data is not yet available for this compound.

No side effects recorded

Side effect data is not yet available for this drug.

Foire aux questions

A small-molecule thrombopoietin receptor agonist used to treat low platelet counts in adults with chronic liver disease preparing for a scheduled procedure. It stimulates the bone marrow to produce more platelets.

Binds to and activates its target receptor, mimicking the action of the endogenous ligand to produce a specific physiological response.

Yes, Lusutrombopag is an approved drug. It has reached clinical phase 4. It is classified as a Small molecule.

{# References & Data Sources section for drug detail pages. Renders standard pharmacological database links plus the drug's data_sources field. #}

References & Data Sources

  • ChEMBL — European Bioinformatics Institute (EBI). CHEMBL2107831. Open-access bioactivity database.
  • PubChem — National Center for Biotechnology Information (NCBI). CID 49843517. Chemical information database.

Data aggregated from publicly available pharmacological databases. Last updated 2026-03-04.

Avertissement médical

This content is for educational and informational purposes only. It is not a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making medication decisions.

Data sources: ChEMBL, PubChem, DailyMed.